TNFα inhibitor-associated psoriatic alopecia (TiAPA) is an infrequent complication of treatment with infliximab and adalimumab in particular, and surprisingly is more common in subjects with IBD than those treated for psoriasis or PsA. The gene discussed is TNF; the disease is psoriasis.